Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Saved in:
| Title: | Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial. |
|---|---|
| Authors: | Xia, Zhongjun1 (AUTHOR), Leng, Yun2 (AUTHOR), Fang, Baijun3 (AUTHOR), Liang, Yang1 (AUTHOR), Li, Wei4 (AUTHOR), Fu, Chengcheng5 (AUTHOR), Yang, Linhua6 (AUTHOR), Ke, Xiaoyan7 (AUTHOR), Jiang, Hua8 (AUTHOR), Weng, Jianyu9 (AUTHOR), Liu, Li10 (AUTHOR), Zhao, Yaozhong11 (AUTHOR), Zhang, Xuejun12 (AUTHOR), Huang, Zhongxia2 (AUTHOR), Liu, Aichun13 (AUTHOR), Shi, Qingzhi14 (AUTHOR), Gao, Yuhuan15 (AUTHOR), Chen, Xiequn16 (AUTHOR), Pan, Ling17 (AUTHOR), Cai, Zhen18 (AUTHOR) |
| Source: | BMC Cancer. 10/14/2023, Vol. 23 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
